April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
ATM Activation by HSV-1: a Critical and Targetable Step in Herpes Simplex Keratitis
Author Affiliations & Notes
  • Oleg Alekseev
    Biochemistry & Molecular Biology, Drexel Univ College of Medicine, Philadelphia, PA
  • Kelly Donovan
    Biochemistry & Molecular Biology, Drexel Univ College of Medicine, Philadelphia, PA
  • Jane Azizkhan-Clifford
    Biochemistry & Molecular Biology, Drexel Univ College of Medicine, Philadelphia, PA
  • Footnotes
    Commercial Relationships Oleg Alekseev, None; Kelly Donovan, None; Jane Azizkhan-Clifford, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1691. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Oleg Alekseev, Kelly Donovan, Jane Azizkhan-Clifford; ATM Activation by HSV-1: a Critical and Targetable Step in Herpes Simplex Keratitis. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1691.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Herpes keratitis (HK) remains the leading cause of cornea-derived blindness in the developed world, despite the availability of effective antiviral drugs. Treatment toxicity and the emergence of drug resistance highlight the need for additional therapeutic approaches. We examined ataxia telangiectasia mutated (ATM), an apical kinase in the host DNA damage response, as a potential new target for the treatment of HK.

Methods: Small molecule inhibitor of ATM (KU-55933) was used to treat HSV-1 infection in cultured human corneal epithelial cells, explanted human and rabbit corneas, and in mice. Infection productivity was assayed by plaque assay, real time PCR, Western blot, and disease scoring. Mechanistic studies relied on mutant viral strains, bacterial artificial chromosomes, and comet assays.

Results: Robust and early ATM activation was detected in HSV-1-infected human corneal epithelial cells. Inhibition of ATM greatly suppressed viral replication in cultured cells and in explanted human and rabbit corneas, and reduced the severity of stromal keratitis in mice. The antiviral effect of KU-55933 in combination with acyclovir was additive, and KU-55933 suppressed replication of a drug-resistant HSV-1 strain. KU-55933 caused minimal toxicity, as monitored by clonogenic survival assay and fluorescein staining. Mechanistic studies show that ATM activation during HSV-1 infection occurs in the absence of DNA damage and is independent of viral genome replication, tegument proteins alone, or ICP0. Results of further investigations into the mechanisms behind ATM activation and its downstream significance will also be presented.

Conclusions: This study identifies ATM as a potential target for the treatment of HK and delves into the mechanisms underlying its involvement. ATM inhibition by KU-55933 reduces epithelial infection and stromal disease severity without producing appreciable toxicity. Additional experiments reveal a potential mechanistic model of ATM activation and subsequent significance in HSV-1 infection.

Keywords: 545 herpes simplex virus • 573 keratitis • 482 cornea: epithelium  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×